Levreault, EleniKendall, ClaireLiddy, Clare2017-11-102017-11-102016-09-29http://hdl.handle.net/10393/36912https://doi.org/10.20381/ruor-21184The Patient Activation Measure (PAM®) survey is a validated tool used to assess a patient’s level of engagement. It uses a 4-point Likert scale to assess patient activation levels. The objectives of this study were to 1) establish a baseline measure of activation using the PAM® amongst people living with HIV to help inform future self-management frameworks, and 2) compare PAM® scores between people living with HIV and with diabetes mellitus (DM). DM is a chronic disease for which self-management been extensively studied and reported on in the literature, and will provide a strong basis for comparison. To our knowledge, this is the first study comparing PAM® survey scores across chronic conditions.enHIVpatient activationdiabetes mellituschronic diseasePatient Activation Levels Among Patients Living with HIV Compared to Patients Living with Diabetes MellitusPresentation